Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fresh Whole Blood Reduces Transfusion-Related Illnesses for Pediatric Heart Surgery

By LabMedica International staff writers
Posted on 11 May 2015
The use of fresh whole blood from single donors may reduce the risk of lifelong complications for young children undergoing heart surgery.

At present, component blood consisting of blood parts such as red blood cells, platelets or plasma from multiple donors tends to be the standard form of blood used for transfusion among children undergoing heart surgery, but the use of component blood exposes children to multiple donors, and raises their risk of transfusion-related complications.

Critical care physicians at The Children's Hospital of Philadelphia (Philadelphia, PA, USA) assessed the blood bank records and surgical registry data from 1995 to 2010 of 4,111 pediatric patients with an average age of 94 days. Of these patients, 3,836 received fresh whole blood, while 252 received blood components due to the unavailability of fresh whole blood. Blood was obtained from daily donations 24 to 48 hours before operation, underwent standard labeling and testing for transmissible disease, was stored at 4 °C, and was delivered to the hospital the evening before operation.

The investigators found that the youngest patients whose heart procedures were complex were exposed to the highest number of blood donors, while older patients who underwent simpler heart procedures were exposed to the fewest number of blood donors. On comparing the number of blood donor exposures among children in the program with those detailed in published reports of component blood use, they found that overall the use of fresh whole blood was associated with a lower number of donor exposures. This indicated that the use of fresh whole blood can lower the risk of transfusion-related illnesses among pediatric heart surgery patients.

The authors concluded that most young patients undergoing complex surgical procedures will continue to require multiple transfusions. For those patients, they believe that their experience with the use of fresh whole blood demonstrates a consistent reduction in donor exposure compared with the exclusive use of components and potentially reduces the risks of transfusion. Their experience also demonstrates that the provision of fresh whole blood, although logistically complicated and dependent on cooperation and careful communication, is feasible as a sustainable operating protocol between a blood center, a blood bank and the pediatric cardiothoracic surgery service they support. The study was published on March 25, 2015, in the journal the Annals of Thoracic Surgery.

Related Links:

The Children's Hospital of Philadelphia



Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit
New
Myeloperoxidase Assay
IDK MPO ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.